Evidence map›Paper›PMID 38857308›Full record

ArticlePLoS computational biology2024

Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics.

Roberth Anthony Rojas Chávez, Mohammad Fili, Changze Han, Syed A Rahman, Isaiah G L Bicar, Sullivan Gregory, Annika Helverson, Guiping Hu, Benjamin W Darbro, Jishnu Das and 2 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Roberth Anthony Rojas ChávezDepartment of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0002-7023-2718
Mohammad FiliDepartment of Industrial and Manufacturing Systems Engineering, Iowa State University, Ames, Iowa, United States of America.
Changze HanDepartment of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America.
Syed A RahmanCenter for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Isaiah G L BicarDepartment of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America.
Sullivan GregoryDepartment of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America.
Annika HelversonDepartment of Biostatistics, College of Public Health, The University of Iowa, Iowa City, Iowa, United States of America.
Guiping HuDepartment of Industrial and Manufacturing Systems Engineering, Iowa State University, Ames, Iowa, United States of America.
Benjamin W DarbroDepartment of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States of America.
Jishnu DasCenter for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Grant D BrownDepartment of Biostatistics, College of Public Health, The University of Iowa, Iowa City, Iowa, United States of America.
Hillel HaimDepartment of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America.ORCID 0000-0002-6071-5089

Funding

Training in Molecular Virology, Viral Pathogenesis and Viral VectorsT32AI007533 · NIAID · UNIVERSITY OF IOWA · PI Stanley Perlman · 1998 to 2026
$2.5M
Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious diseaseDP2AI164325 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAS, JISHNU · 2021 to 2025
$2.4M
Predicting HIV-1 escape from therapeutics in vitro and in vivo - toward personalizing medicine for people living with HIVR01AI170205 · NIAID · UNIVERSITY OF IOWA · PI Hillel Haim · 2023 to 2026
$2.3M
NIAID NIH HHS DP2 AI164325NIAID NIH HHS R01 AI170205NIAID NIH HHS T32 AI007533
6 · The paper itself

Abstract

New sublineages of SARS-CoV-2 variants-of-concern (VOCs) continuously emerge with mutations in the spike glycoprotein. In most cases, the sublineage-defining mutations vary between the VOCs. It is unclear whether these differences reflect lineage-specific likelihoods for mutations at each spike position or the stochastic nature of their appearance. Here we show that SARS-CoV-2 lineages have distinct evolutionary spaces (a probabilistic definition of the sequence states that can be occupied by expanding virus subpopulations). This space can be accurately inferred from the patterns of amino acid variability at the whole-protein level. Robust networks of co-variable sites identify the highest-likelihood mutations in new VOC sublineages and predict remarkably well the emergence of subvariants with resistance mutations to COVID-19 therapeutics. Our studies reveal the contribution of low frequency variant patterns at heterologous sites across the protein to accurate prediction of the changes at each position of interest.

Indexed as

COVID-19Drug Resistance, ViralEvolution, MolecularMutationSARS-CoV-2Spike Glycoprotein, CoronavirusAntiviral AgentsComputational BiologyCOVID-19 Drug TreatmentHumansAntiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID38857308
PMCPMC11192331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.